Email continues to be the most preferred source of marketing content for healthcare professionals in 2019. Many HCPs say they are generally ok with getting the promotional emails the industry is sending. Dive into the facts and how to craft messages that connect.

The final stages of maximizing your pharma marketing spend come down to operational excellence. But how do you measure the results?

One of the biggest challenges that launch brands in unique therapeutic areas face is identifying the right target audience for both unbranded and branded messaging. The right audience can impact speed to market, awareness and trial, business impact, and ROI.

Every single marketing message has strategy behind it. Whether or not that strategy is strategic or not is ultimately up to the marketer.

As the 2019 Medicare Annual Enrollment Period approaches, it’s more important than ever for insurers to understand their customers.

In this second part of the four-part blog post series, “In Pursuit of Pharma Marketing Excellence”, I’ll discuss the actual email process and the importance of optimization.

How do marketers determine the proper number of touches during the Medicare AEP campaign to drive lead volume through direct mail? The best way is to leverage audience analytics to determine the investment.

The time to embrace people-based marketing in pharma is now—but how? Now more than ever, pharma marketers have an opportunity to build personal and direct relationships at scale and can find opportunities to leverage people-based marketing (PBM) to reach both consumers (patients, caregivers) and healthcare providers (HCPs) on a deeper level, and drive measurable results.